The integration seeks to enable multi-omic biomarker detection at unprecedented speed, scale, and cost SAN DIEGO — Pleno Inc., a multi-omic instrument platform company revolutionizing biological target detection for clinical testing and biomedical research, today announced successful deployment of the first of its RAPTOR instruments integrated with industry-leading TotalSeq™ antibodies from BioLegend, part of Revvity. This marks the […]

New Advancement Builds on 25-Year Commitment to T-Cell Research INDIANAPOLIS – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues to lead the way with first-to-market concepts to help laboratories achieve goals faster and with greater accuracy. The company today announces it has developed the first commercially available anti-TRBC2 conjugated antibody for flow cytometry, […]

New Advancement Builds on 25-Year Commitment to T-Cell Research   INDIANAPOLIS – Beckman Coulter Life Sciences, a global leader in laboratory automation and innovation, continues to lead the way with first-to-market concepts to help laboratories achieve goals faster and with greater accuracy. The company today announces it has developed the first commercially available anti-TRBC2 conjugated […]

LAKEWOOD, Colo.  — Mesa Laboratories, Inc. (NASDAQ:MLAB) (“Mesa”, “we”, “us”, or “our”), a global leader in the design and manufacturing of life science tools and critical quality control solutions, today announced the appointment of Mark Capone to its Board of Directors (the “Board”), effective January 5, 2024. Dr. John Sullivan, Ph.D., Chairman of the Board […]

PARIS, France – Interactomics pioneer Depixus has launched its game-changing MAGNA technology access program with the deployment of the first ‘MAGNA One’ beta prototype instrument in the laboratory of Professor Jean-François Allemand, Department of Physics at the École Normale Supérieure (ENS), Paris. Based on magnetic force spectroscopy, MAGNA is the first technology to deliver direct, simultaneous, […]

SOUTH SAN FRANCISCO, Calif. —  Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced the appointment of Adam Laponis as chief financial officer. Mr. Laponis brings experience across small cap and Fortune 50 companies along with a track record of collaborating across teams to drive […]

Establishes Leading Platform of Complementary Multi-omic Technologies with Enhanced Scale and Commercial Reach; Strengthened Balance Sheet to Self-Fund Future Growth Initiatives SOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, today announced that it has completed its merger with SomaLogic, […]

While the business of Biotage continues to perform well, following consultation with the Board Tomas Blomquist will leave his role as CEO & President of Biotage AB with immediate effect. The Chairman of the Board, Torben Jørgensen, has been appointed by the Board of Directors as interim CEO while the process of recruiting a new […]

SOUTH SAN FRANCISCO, Calif. — Standard BioTools Inc. (Nasdaq: LAB), driven by a bold purpose – Unleashing tools to accelerate breakthroughs in human health, today announced that its stockholders voted to approve all proposals required to be approved in connection with the pending merger with SomaLogic (Nasdaq: SLGC) at its Special Meeting of Stockholders. “We are pleased […]

Successful Early Access Program results in purchase orders for 10 systems and installations at 6 institutions in 2023 Fremont, CA, US – Alamar Biosciences, a company powering precision proteomics to enable the earliest detection of disease, announced today the commercial launch of the ARGO HT System for push-button, high sensitivity analysis of proteins in biofluids […]